{"id":22042,"date":"2010-07-22T14:30:00","date_gmt":"2010-07-22T14:30:00","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=22042"},"modified":"2026-04-02T17:37:59","modified_gmt":"2026-04-02T17:37:59","slug":"cum-aduce-o-companie-de-generice-un-original-in-romania","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=22042","title":{"rendered":"Cum aduce o companie de generice un original in Romania"},"content":{"rendered":"<p>Daiichi Sankyo a intrat intr-un acord cu Sanofi-Aventis, in<br \/>\n1993, privind licenta pentru fabricarea si comercializarea de<br \/>\nlevofloxacin acoperind zone precum: Europa, Africa, Orientul<br \/>\nMijlociu, America de Sud si o parte din Asia. Incepand din acel<br \/>\nmoment, Sanofi-Aventis a lansat produsul in mai mult de 90 de tari<br \/>\nsub denumirea comerciala Tavanic. La inceputul acestui an, Daiichi<br \/>\nSankyo si Sanofi-Aventis, in calitate de parteneri, au fost de<br \/>\nacord sa transfere drepturile de comercializare a Tavanic in<br \/>\nRomania si Africa de Sud de la Sanofi-Aventis catre Ranbaxy. Este<br \/>\npreconizat ca transferul sa intre in vigoare in august 2010 pentru<br \/>\nRomania, iar in ianuarie 2012 pentru Africa de Sud. Avand in vedere<br \/>\nrelatia lor de lunga durata, partenerii au convenit ca<br \/>\nSanofi-Aventis va continua fabricarea de produse finite Tavanic<br \/>\npentru aceste tari.<\/p>\n<p>Comercializarea Tavanic de catre Sanofi-Aventis ramane<br \/>\nneschimbata in celelalte piete.<\/p>\n<p>Levofloxacin este un agent antibacterian sintetic apartinand din<br \/>\nclasa fluorochinolone, care este utilizat pentru a trata o gama<br \/>\nlarga de infectii. Initial descoperit de Daiichi Sankyo,<br \/>\nlevofloxacin a fost lansat in Japonia in 1993 sub numele de marca<br \/>\nCravit. Levofloxacin este disponibil in prezent in mai mult de 120<br \/>\nde tari din intreaga lume prin intermediul acordarii de licente<br \/>\ncatre parteneri de prestigiu, precum Johnson&#038;Johnson,<br \/>\nSanofi-Aventis si GlaxoSmithKline.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Daiichi Sankyo si Ranbaxy au anuntat planurile de a utiliza prezenta Ranbaxy in Romania si Africa de Sud pentru a comercializa Tavanic (levofloxacin), agent antibacterian sintetic, descoperit initial de catre Daiichi Sankyo.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[511],"tags":[16563,8088,323,8434,98,18504],"class_list":["post-22042","post","type-post","status-publish","format-standard","hentry","category-afaceri","tag-comercializare","tag-farma","tag-medicamente","tag-ranbaxy","tag-romania","tag-tavanic"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/22042","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22042"}],"version-history":[{"count":1,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/22042\/revisions"}],"predecessor-version":[{"id":41678,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/22042\/revisions\/41678"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22042"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22042"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22042"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}